FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2471966772> ?p ?o ?g. }

• W2471966772 endingPage "182" @default.
• W2471966772 startingPage "169" @default.
• W2471966772 abstract "Multiple sclerosis (MS) is more common in women and can occur during childbearing years; thus, information on outcomes following exposure to MS therapy during pregnancy is important. No formal studies of daclizumab have been conducted in pregnant women. Here, we report available nonclinical and clinical data on pregnancy outcomes from the daclizumab clinical study program. Reproductive and developmental toxicity studies were conducted in cynomolgus monkeys. Reports of pregnancies that occurred during the daclizumab clinical study program through March 9, 2015 were collated and summarized. In the event of pregnancy, daclizumab was discontinued and safety monitoring continued. Studies in cynomolgus monkeys showed no daclizumab-related effects on maternal well-being, embryo–fetal development, indirect fertility end points, and pre- and postnatal development and growth. Across the clinical study program, 38 pregnancies were reported in 36 daclizumab-exposed women (on treatment ≤6 months from last dose); 20 resulted in live births and four (11%) in spontaneous abortions or miscarriages. One congenital heart defect (complex transposition of great vessels) occurred in one live birth (considered unrelated to daclizumab); daclizumab had been discontinued and intramuscular interferon beta-1a and lisinopril were used at conception. Eight women had an elective termination, two had an ectopic pregnancy, and two were lost to follow-up; two pregnancy outcomes are pending. Six additional pregnancies occurred in five women >6 months after their last daclizumab dose; in one additional pregnancy, exposure was unknown. Spontaneous abortion rate in daclizumab-exposed women was consistent with early pregnancy loss in the general population (12%–26%). Data on pregnancies exposed to daclizumab do not suggest an increased risk of adverse fetal or maternal outcomes, although the numbers are too small for definitive conclusions. NCT00390221, NCT01064401, NCT01462318, NCT00870740, NCT01051349, and NCT01797965. Biogen and AbbVie Biotherapeutics Inc." @default.
• W2471966772 created "2016-07-22" @default.
• W2471966772 creator A5018185771 @default.
• W2471966772 creator A5020016996 @default.
• W2471966772 creator A5028822603 @default.
• W2471966772 creator A5044400390 @default.
• W2471966772 creator A5045233835 @default.
• W2471966772 creator A5062220148 @default.
• W2471966772 creator A5067994259 @default.
• W2471966772 creator A5068891061 @default.
• W2471966772 creator A5078067575 @default.
• W2471966772 date "2016-07-13" @default.
• W2471966772 modified "2023-10-12" @default.
• W2471966772 title "Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program" @default.
• W2471966772 cites W1531784929 @default.
• W2471966772 cites W1533388638 @default.
• W2471966772 cites W1969523085 @default.
• W2471966772 cites W1987843706 @default.
• W2471966772 cites W1996662567 @default.
• W2471966772 cites W2027470770 @default.
• W2471966772 cites W2037921819 @default.
• W2471966772 cites W2039975114 @default.
• W2471966772 cites W2040969396 @default.
• W2471966772 cites W2053553562 @default.
• W2471966772 cites W2057540814 @default.
• W2471966772 cites W2060464270 @default.
• W2471966772 cites W2072924355 @default.
• W2471966772 cites W2078804817 @default.
• W2471966772 cites W2098308943 @default.
• W2471966772 cites W2112079575 @default.
• W2471966772 cites W2124016103 @default.
• W2471966772 cites W2143486392 @default.
• W2471966772 cites W2151842188 @default.
• W2471966772 cites W2167414238 @default.
• W2471966772 cites W2168919398 @default.
• W2471966772 cites W2171375112 @default.
• W2471966772 cites W2263947346 @default.
• W2471966772 cites W2330965779 @default.
• W2471966772 cites W2512790072 @default.
• W2471966772 cites W69805495 @default.
• W2471966772 doi "https://doi.org/10.1007/s40120-016-0048-2" @default.
• W2471966772 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5130915" @default.
• W2471966772 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27411694" @default.
• W2471966772 hasPublicationYear "2016" @default.
• W2471966772 type Work @default.
• W2471966772 sameAs 2471966772 @default.
• W2471966772 citedByCount "15" @default.
• W2471966772 countsByYear W24719667722016 @default.
• W2471966772 countsByYear W24719667722017 @default.
• W2471966772 countsByYear W24719667722018 @default.
• W2471966772 countsByYear W24719667722019 @default.
• W2471966772 countsByYear W24719667722021 @default.
• W2471966772 countsByYear W24719667722023 @default.
• W2471966772 crossrefType "journal-article" @default.
• W2471966772 hasAuthorship W2471966772A5018185771 @default.
• W2471966772 hasAuthorship W2471966772A5020016996 @default.
• W2471966772 hasAuthorship W2471966772A5028822603 @default.
• W2471966772 hasAuthorship W2471966772A5044400390 @default.
• W2471966772 hasAuthorship W2471966772A5045233835 @default.
• W2471966772 hasAuthorship W2471966772A5062220148 @default.
• W2471966772 hasAuthorship W2471966772A5067994259 @default.
• W2471966772 hasAuthorship W2471966772A5068891061 @default.
• W2471966772 hasAuthorship W2471966772A5078067575 @default.
• W2471966772 hasBestOaLocation W24719667721 @default.
• W2471966772 hasConcept C126322002 @default.
• W2471966772 hasConcept C131872663 @default.
• W2471966772 hasConcept C2779234561 @default.
• W2471966772 hasConcept C2779719350 @default.
• W2471966772 hasConcept C2908647359 @default.
• W2471966772 hasConcept C2909675724 @default.
• W2471966772 hasConcept C2911091166 @default.
• W2471966772 hasConcept C29456083 @default.
• W2471966772 hasConcept C54355233 @default.
• W2471966772 hasConcept C71924100 @default.
• W2471966772 hasConcept C86803240 @default.
• W2471966772 hasConcept C99454951 @default.
• W2471966772 hasConceptScore W2471966772C126322002 @default.
• W2471966772 hasConceptScore W2471966772C131872663 @default.
• W2471966772 hasConceptScore W2471966772C2779234561 @default.
• W2471966772 hasConceptScore W2471966772C2779719350 @default.
• W2471966772 hasConceptScore W2471966772C2908647359 @default.
• W2471966772 hasConceptScore W2471966772C2909675724 @default.
• W2471966772 hasConceptScore W2471966772C2911091166 @default.
• W2471966772 hasConceptScore W2471966772C29456083 @default.
• W2471966772 hasConceptScore W2471966772C54355233 @default.
• W2471966772 hasConceptScore W2471966772C71924100 @default.
• W2471966772 hasConceptScore W2471966772C86803240 @default.
• W2471966772 hasConceptScore W2471966772C99454951 @default.
• W2471966772 hasFunder F4320308604 @default.
• W2471966772 hasIssue "2" @default.
• W2471966772 hasLocation W24719667721 @default.
• W2471966772 hasLocation W24719667722 @default.
• W2471966772 hasLocation W24719667723 @default.
• W2471966772 hasLocation W24719667724 @default.
• W2471966772 hasOpenAccess W2471966772 @default.
• W2471966772 hasPrimaryLocation W24719667721 @default.
• W2471966772 hasRelatedWork W1999001339 @default.
• W2471966772 hasRelatedWork W2008490960 @default.

• next